FindTrial
Sign In

To administer sodium phenylbutylate orally at less than 200mg/kg.

2 trials

Sponsors

Juntendo University

Conditions

Refractory pediatric cholestasis disease (progressive familial intrahepatic cholestasis, primary biliary cirrhosis, primary sclerosing cholangitis, Alagille syndrome, drug-induced cholestatic liver injury, biliary atresia, etc)urea cycle disorder

Phase 1

A pharmacokinetic study of sodium phenylbutyrate in refractory pediatric cholestasis disease
Active, not recruitingJPRN-UMIN000025037
Juntendo UniversityRefractory pediatric cholestasis disease (progressive familial intrahepatic cholestasis, primary biliary cirrhosis, primary sclerosing cholangitis, Alagille syndrome, drug-induced cholestatic liver injury, biliary atresia, etc)
Start: 2016-11-14Target: 10Updated: 2026-06-29
A pharmacokinetic study of sodium phenylbutyrate in urea cycle disorder
Active, not recruitingJPRN-UMIN000025627
Juntendo Universityurea cycle disorder
Start: 2017-01-11Target: 10Updated: 2026-06-29